Skip to Content

Zurampic Approval History

  • FDA approved: Yes (First approved December 22nd, 2015)
  • Brand name: Zurampic
  • Generic name: lesinurad
  • Dosage form: Tablets
  • Company: AstraZeneca Pharmaceuticals LP
  • Treatment for: Gout

Zurampic (lesinurad) is a URAT1 inhibitor indicated for the combination treatment of hyperuricemia associated with gout.

Development History and FDA Approval Process for Zurampic

DateArticle
Dec 22, 2015Approval FDA Approves Zurampic (lesinurad) to Treat High Blood Uric Acid Levels Associated with Gout
Oct 23, 2015FDA Advisory Committee Recommends the Approval of Lesinurad for Gout Patients
Nov 16, 2014AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol for Gout

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide